Catalog No.
RHC06503
Species reactivity
Human
Host species
Mouse
Isotype
IgG1
Clonality
Monoclonal
Tested applications
ELISA: 1:10000, FCM: 1:200-1:400, IF: 1:200-1:1000
Target
Apo B-48, Apo B-100, Apolipoprotein B-100, APOB
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% as determined by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P04114
Applications
ELISA, FCM, IF
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% Sodium Azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
Clone ID
R2Y57
Robust Serum Proteomic Signatures of APOE2., PMID:40501769
An evaluation of recaticimab for the treatment of hypercholesterolemia., PMID:40380894
An ANGPTL4 inhibitory antibody safely improves lipid profiles in non-human primates., PMID:40360349
RNA interference versus antibody-based PCSK9 inhibition for the prevention of cardiovascular disease: A drug-target Mendelian randomization study., PMID:40347490
Tafolecimab, a Third Monoclonal Antibody for PCSK9 as the Novel Lipid-Lowering Drug Around the World: A Narrative Review., PMID:40167967
Analysis of non-cholesterol sterols and fatty acids in patients with graves' orbitopathy: insights into lipid metabolism in relation to the clinical phenotype of disease., PMID:40100571
Involvement of Fe(III) in the formation of immunoglobulin G-enriched protein aggregates in human plasma., PMID:40058718
Achieved levels of apolipoprotein B and plaque composition after acute coronary syndromes: Insights from HUYGENS., PMID:40020597
A Novel ELISA System for Measuring Modified LDL-Adiponectin Complex., PMID:39993736
Structure of apolipoprotein B100 bound to the low-density lipoprotein receptor., PMID:39663455
CDR identification, epitope mapping and binding affinity determination of novel monoclonal antibodies generated against human apolipoprotein B-100., PMID:39454741
Risk stratification analysis of recurrent myocardial infarction in Indian population using inflammatory, lipid, thrombotic and extracellular matrix remodeling markers., PMID:39351476
Spurious dyslipidemia due to paraprotein in a patient with Waldenström macroglobulinemia., PMID:39111648
Proteomic Analysis of Human Chylomicron Remnants Isolated by Apolipoprotein B-48 Immunoprecipitation., PMID:39085140
Advances in nucleic acid-targeted therapies for cardiovascular disease prevention., PMID:38970537
Coronary Artery Calcification Progression in Patients With Systemic Lupus Erythematosus., PMID:38950947
The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study., PMID:38713460
Acoustic Delivery of Plasma Low-Density Lipoprotein into Liver via ApoB100-Targeted Microbubbles Inhibits Atherosclerotic Plaque Growth., PMID:38700017
Persistence and Adherence to PCSK9 Inhibitor Monoclonal Antibodies Versus Ezetimibe in Real-World Settings., PMID:38691317
Identification of apolipoprotein B-reactive CDR3 motifs allows tracking of atherosclerosis-related memory CD4+T cells in multiple donors., PMID:38571941
Proteomic Analysis of Egg Yolk Proteins During Embryonic Development in Wanxi White Goose., PMID:38433387
ANGPTL3 and ApoC-III inhibitors for treating hypertriglyceridemia in context: horses for courses?, PMID:38372218
Anti-Lipoprotein Lipase Antibody as a Useful Marker for Plaque Vulnerability in Patients with Stable Angina., PMID:38325861
New Advances in Rapid Pretreatment for Small Dense LDL Cholesterol Measurement Using Shear Horizontal Surface Acoustic Wave (SH-SAW) Technology., PMID:38256117
Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk., PMID:38243829
Based on whole-exome sequencing to explore the rule of Herceptin and TKI resistance in breast cancer patients., PMID:38243282
A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice., PMID:38174870
Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study., PMID:38161051
The analysis of serum lipids profile in Guillain-Barre syndrome., PMID:38143756
Stent composition and immune response after long-term coronary angioplasty., PMID:37934202
Evinacumab for Pediatric Patients With Homozygous Familial Hypercholesterolemia., PMID:37860863
Tafolecimab: First Approval., PMID:37847461
Effect of Intensive Lipid-Lowering Therapy on Coronary Plaque Stabilization Derived from Optical Coherence Tomography: a Meta-analysis and Meta-regression., PMID:37815648
New Biological Therapies for Low-Density Lipoprotein Cholesterol., PMID:37562541
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial., PMID:37517914
Established and Emerging Lipid-Lowering Drugs for Primary and Secondary Cardiovascular Prevention., PMID:37486464
Establishment of a comprehensive diagnostic model for neuromyelitis optica spectrum disorders based on the analysis of laboratory indicators and clinical data., PMID:37191810
Metabolic profile in women with bulimia nervosa or binge-eating disorder before and after treatment: secondary analysis from the randomized PED-t trial., PMID:37103592
A Preliminary Study in Immune Response of BALB/c and C57BL/6 Mice with a Locally Allergic Rhinitis Model., PMID:36797980
Altered serum lipid levels are associated with prognosis of diffuse large B cell lymphoma and influenced by utility of rituximab., PMID:36670246
Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia., PMID:36384662
Lp(a), oxidized phospholipids and oxidation-specific epitopes are increased in subjects with keloid formation., PMID:36320028
Considerations for Use of Pharmacodynamic Biomarkers to Support Biosimilar Development - (I) A Randomized Trial with PCSK9 Inhibitors., PMID:36282186
PCSK9 is minimally associated with HDL but impairs the anti-atherosclerotic HDL effects on endothelial cell activation., PMID:36067830
[Serum Lipid Levels and Their Prognostic Significance in Patients with Multiple Myeloma]., PMID:35981378
Intervention of Shugan Xiaozhi Decoction on Nonalcoholic Fatty Liver Disease via Mediating Gut-Liver Axis., PMID:35837380
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab., PMID:35770629
The Progression of Treatment for Refractory Hypercholesterolemia: Focus on the Prospect of Gene Therapy., PMID:35754818
Circulating Autoantibodies Recognizing Immunodominant Epitopes From Human Apolipoprotein B Associate With Cardiometabolic Risk Factors, but Not With Atherosclerotic Disease., PMID:35479271
For research use only. Not for human or drug use.
